Bangor Savings Bank Trims Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Bangor Savings Bank cut its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 13.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,640 shares of the company’s stock after selling 886 shares during the period. Bangor Savings Bank’s holdings in Procter & Gamble were worth $915,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of PG. HighPoint Advisor Group LLC acquired a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $17,696,000. Dfpg Investments LLC increased its stake in Procter & Gamble by 1.7% in the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after buying an additional 424 shares during the period. Campbell Wealth Management raised its position in Procter & Gamble by 13.1% during the 4th quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock worth $291,000 after buying an additional 231 shares during the last quarter. Herold Advisors Inc. lifted its stake in shares of Procter & Gamble by 2.2% in the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock worth $3,897,000 after acquiring an additional 581 shares during the period. Finally, Metis Global Partners LLC boosted its holdings in shares of Procter & Gamble by 15.7% in the fourth quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after acquiring an additional 15,599 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Trading Up 0.4 %

Shares of PG stock opened at $168.26 on Monday. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $168.97. The company has a market capitalization of $397.12 billion, a price-to-earnings ratio of 27.49, a PEG ratio of 3.40 and a beta of 0.42. The firm has a 50-day moving average price of $164.59 and a 200 day moving average price of $158.17. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The company’s quarterly revenue was up .6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 earnings per share. Research analysts forecast that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a $1.0065 dividend. The ex-dividend date was Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.39%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s payout ratio is currently 65.85%.

Insider Activity at Procter & Gamble

In other news, insider Moses Victor Javier Aguilar sold 9,149 shares of the stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $167.72, for a total transaction of $1,534,470.28. Following the transaction, the insider now directly owns 12,929 shares in the company, valued at approximately $2,168,451.88. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares in the company, valued at approximately $634,634. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Moses Victor Javier Aguilar sold 9,149 shares of Procter & Gamble stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $167.72, for a total value of $1,534,470.28. Following the completion of the transaction, the insider now directly owns 12,929 shares in the company, valued at $2,168,451.88. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 154,544 shares of company stock worth $25,413,051. 0.17% of the stock is currently owned by insiders.

Analysts Set New Price Targets

PG has been the subject of a number of recent analyst reports. The Goldman Sachs Group started coverage on shares of Procter & Gamble in a research report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective for the company. Deutsche Bank Aktiengesellschaft reduced their price target on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a report on Monday, April 22nd. Barclays upped their price objective on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a report on Tuesday, April 23rd. BNP Paribas assumed coverage on Procter & Gamble in a report on Monday. They issued an “outperform” rating and a $187.00 target price for the company. Finally, Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and upped their price target for the stock from $160.00 to $175.00 in a research note on Monday, March 11th. Seven analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $170.72.

Get Our Latest Stock Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.